04Feb 2018

CORRELATION BETWEEN CLINICAL FINDINGS AND FUNDUS FLUORESCEIN ANGIOGRAPHY FINDINGS IN PATIENTS WITH PREPROLIFERATIVE DIABETIC RETINOPATHY.

  • Principal/Dean, SKIMS Medical College.
Crossref Cited-by Linking logo

  • Abstract
  • References
  • Cite This Article as
  • Corresponding Author

Fluorescein angiography has been extremely valuable for expanding our knowledge to visualize the chorioretinal circulation and in evaluating retinal vascular disorders. The angiogram is used to determine the extent of damage, to develop treatment plan and to monitor the results of treatment. In diabetic retinopathy the angiogram is useful in identifying the extent of ischemia, the location of micro aneurysms, the presence of intraretinal microvascular abnormalities (IRMA) that can only be confirmed on angiogram; neovascularization and the extent of macular edema. Fluorescein angiography is an excellent method to display the retinal capillaries in detail to show the pathologic changes because the retinal pigment epithelium provides a good background. FFA is not only useful for diagnosis but also to gauge the progression and management of diabetic retinopathy (DR). FFA is a therapeutic guide to laser photocoagulation treatment for several retinal vascular diseases. In this study, we aimed at highlighting the problems that can occur in early diagnosis and accurate staging of diabetic retinopathy and importance of fluorescein angiography in monitoring diabetic patients.The present study was a hospital based prospective study conducted from November 2015 to April 2017 in the department of Ophthalmology SKIMS Medical College Hospital, Srinagar. Patients older than 12 years of age suffering from Diabetes Mellitus with clinical findings consistent with pre-proliferative diabetic retinopathy were included for the purpose of the study. Patients younger than 12 years of age, patients with hazy media, pregnant women, immunocompromised status patients, patients with hypersensitivity to fluorescein dye or any contraindication to fluorescein dye were excluded from the study. In our study FFA proved to be an important tool to evaluate the lesions of PPDR, which were not detectable on ophthalmoscopy and slit lamp biomicroscopy, such as areas of capillary nonperfusion. IRMA were also best picked up and differentiated from neovascularisation by means of FFA.

  1. Definition and diagnosis of diabetes mellitus and intermediate hyperglycaemia. Geneva, World Health Organization, 2006.
  2. Usher, M. Dumsky, M. Himaga, T. H. Williamson, S. Nussey and J. Boyce. Automated detection of diabetic retinopathy in digital retinal images: a tool for diabetic retinopathy screening. Journal of the British Diabetic Association 2004; Vol. 21, No.1: pp. 84-90.
  3. N. JebaraniSargunar and R. Sukanesh. Exudates Detection and Classification in Diabetic Retinopathy Images by Texture Segmentation Methods. International Journal of Recent Trends in Engineering 2009 Nov; Vol. 2,No. 4: pp. 148-150.
  4. Luo Gang OpasChutatape and Shankar M. Krishnan. Detection and Measurement of Retinal Vessels in Fundus Images Using Amplitude Modified Second-Order Gaussian Filter. IEEE Transactions on Biomedical Engineering 2002 Feb; Vol. 49, No.2: pp. 168-172.
  5. MonirehEsnaashari, S. AmirhassanMonadjemi and GholamaliNaderian. A Content-based Retinal Image Retrieval Method for Diabetes Related Eye Diseases Diagnosis. International Journal of Research and Reviews in Computer Science (IJRRCS) 2011 Dec; Vol. 2, No. 6: pp. 1222-1227.
  6. Diabetes Care, Diabetic Retinopathy and Diabetic Macular Edema. 2003 Sept; Vol. 26, No. 9: p. 2653 ? 2664.
  7. Early Treatment Diabetic Retinopathy Study Research Group: ETDRS report No 1: photocoagulation for diabetic macular edema. Arch Ophthalmol 1985; 103: 1796?1806.
  8. Swapna T R, ChandanChakroborty. Diabetic maculopathy detection using fundus florescein angiogram images-a review. International Journal of Research in Engineering and Technology. 2014 Dec; Vol. 03 Special Issue15: IWCPS-2014.
  9. Kwiterovich KA, Maguire MG, Murphy RP, Schachat AP, Bressler NM, Bressler SB, et al. Frequency of adverse systemic reactions after fluorescein angiography. Results of a prospective study.1991;98:1139?42.
  10. The diagnosis and management of anaphylaxis. Joint Task Force on Practice Parameters, American Academy of Allergy, Asthma and Immunology, American College of Allergy, Asthma and Immunology, and the Joint Council of Allergy, Asthma and Immunology.J Allergy Clin Immunol.?1998;101:S465?528.
  11. Fineschi V, Monasterolo G, Rosi R, Turillazzi E. Fatal anaphylactic shock during a fluorescein angiography.Forensic Sci Int.?1999;100:137?42.
  12. Hitosugi M, Omura K, Yokoyama T, Kawato H, Motozawa Y, Nagai T, et al. An autopsy case of fatal anaphylactic shock following fluorescein angiography: A case report.Med Sci Law.2004;44:264?5.
  13. Berkow JW, Flower RW, Orth DH, Kelley JS. 2nd ed. San Francisco: American Academy of Ophthalmology; 1997. Fluorescein and Indocyanine Green Angiography.
  14. Aiello LP, Gardner TW, King GL, Blankenship G, Cavallerano JD, Ferris FL 3rd, et al. Diabetic retinopathy. Diabetes Care 1998; 21: 143-56.
  15. Klein R, Klein BE, Moss SE, Davis MD, DeMets DL. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol1984; 102: 520-6.
  16. Rema and Pradeepa. Prevalence and risk factors of diabetic retinopathy 305 Klein R, Klein BEK, Moss SE, Davis MD, DeMets DL. The Wisconsin epidemiologic study of diabetic retinopathy III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Arch Ophthalmol1984; 102: 527-32.
  17. Klein R, Klein BE, Moss SE. Visual impairment in diabetes. Ophthalmology 1984; 91: 1-9.
  18. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes, estimates for the year 2000 and projections for 2030. Diabetes Care 2004; 27: 1047-53.
  19. Abrahamian H, Hornlein B, Gurdet C, Willinger C, Zaruba E, Irsigler K. Insulin-dependent diabetes mellitus: ?EURODIAB IDDM Complications Study? - results from the Vienna center. Wien KlinWochenschr 1994; 106:136-140.
  20. Harris MI. Undiagnosed NIDDM: clinical and public health issues. Diabetes Care 1993; 16: 642-52.
  21. Aiello LM, Rand LI, Briones JC, Wafai MZ, Sebestyen JG. Diabetic retinopathy in Joslin Clinic patients with adult onset diabetes. Ophthalmology 1981; 88: 619-23.
  22. Rema M, Ponnaiya M, Mohan V. Prevalence of retinopathy in non-insulin dependent diabetes mellitus at a diabetes centre in southern India. Diabetes Res Clin Pract1996; 34: 29-36.
  23. Rema M, Premkumar S, Anitha B, Deepa R, Pradeepa R, Mohan V. Prevalence of diabetic retinopathy in urban India: The Chennai Urban Rural Epidemiology Study (CURES) Eye Study, I. Invest Ophthalmol Vis Sci2005; 46: 2328-33.
  24. Harris MI, Klein R, Welborn TA, Knuiman MW. Onset ofNIDDM occurs at least 4-7 years before clinical diagnosis. Diabetes Care 1992; 15: 815-9.
  25. Dandona L, Dandona R, Naduvilath TJ, McCarty CA, RaoGN. Population based assessment of diabetic retinopathy in an urban population in southern India. Br J Ophthal1999; 83: 937-40.
  26. Klein R, Davis MD, Moss SE, Klein BE, DeMets DL. The Wisconsin Epidemiologic Study of Diabetic Retinopathy.A comparison of retinopathy in younger and older onset diabetic persons. AdvExp Med Biol1985; 189: 321-35.
  27. Rema M, Shanthirani CS, Deepa R, Mohan V. Prevalence of diabetic retinopathy in a selected South Indian Population - The Chennai Urban Population Study (CUPS).Diabetes Res Clin Pract2000; 50: S252.
  28. Kohner EM. Diabetic retinopathy. Br Med Bull 1989; 45:148-73.
  29. Rema M, Sujatha P, Pradeepa R. Visual outcomes of panretinal photocoagulation in diabetic retinopathy at one-year follow-up and associated risk factors. Indian J Ophthalmol2005; 53: 93-9.
  30. Fujisawa T, Ikegami H, Yamato E, Kawaguhi Y, Ueda H, Shintani M, et al. Association of plasma fibrinogen level and blood pressure with diabetic retinopathy and renal complications associated with proliferative diabetic retinopathy in type II diabetes mellitus. Diabet Med 1999;16: 522-6.
  31. Kostraba JN, Klein R, Dorman JS, Becker DJ, Drash AL, Maser RE, et al. The Epidemiology of Diabetes Complications Study. IV. Correlates of diabetic background and proliferative retinopathy. Am J Epidemiol1991; 133:381-91.
  32. Klein R, Klein BE, Moss SE, Cruickshanks KJ. The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XVII. The 14-year incidence and progression of diabetic retinopathy and associated risk factors in Type 1 diabetes. Ophthalmology 1998; 105:1801-15.
  33. Chew EY, Klein ML, Ferris FL III, Remaley NA, MurphyRF, Chantry K, et al. Association of elevated serum lipid levels with retinal hard exudates in diabetic retinopathy.Early Treatment Diabetic Retinopathy Study (ETDRS) report 22. Arch Ophthalmol1996; 114: 1079-84.
  34. Ferris FL 3rd, Chew KY, Hoogwerf BJ. Serum lipids and diabetic retinopathy. Early Treatment Diabetic Retinopathy Study Research Group. Diabetes Care 1996; 19: 1291-3.
  35. Klein BEK, Moss SE, Klein R, Surawicz TS. The Wisconsin Epidemiologic Study of Diabetic Retinopathy, XIII: relationship between serum cholesterol to retinopathy and hard exudate. Ophthalmology 1991; 98: 1261-5.
  36. Harding SP, Broadbent DM, Neoh C, et al. Sensitivity and specificity of photography and direct ophthalmoscopy in screening for sight threatening eye disease: The Liverpool Diabetic Eye Study, BMJ 1995; 311: 1131-5.
  37. Adhi MI, Ansari, AA, Aziz MU, et al. Clinical Audit of fundus fluorescein angiograms, Pak J Ophthalmol. 1997; 13: 3?7.
  38. Phillips RP, Rose PG, Sharp PF, et al. Use of temporal information to quantify vascular leakage in fluorescein angiography of retina, Clin Physphysiol Meas. 1990; 11: 81?5.
  39. Muhammad S. Fundus fluorescein angiography, J Postgrad Med InstPesh. 1998; 12: 8-16.
  40. Sato Y, Kamata A, Matsui M. Sub-classification of pre-proliferative diabetic retinopathy, Jpn J Ophthalmol. 1993; 37: 490-8.
  41. Sato Y, Lee Z., The sub-classification and long-term prognosis of pre-proliferative diabetic retinopathy, Jpn J Ophthalmol. 2002; 46: 323-9.
  42. Early treatment diabetic retinopathy study research group.Early Photocoagulation for diabetic retinopathy. ETDRS report 9, Ophthalmology. 1991; 98: 766-85.
  43. Takahashi K, Kishi S, Muraoka K et al. Reperfusion of occluded capillary beds in diabetic retinopathy. Am J Ophthalmol. 1998; 126: 791-7.

[Isha, Govinder Kumar and Reyaz Ahmad Untoo. (2018); CORRELATION BETWEEN CLINICAL FINDINGS AND FUNDUS FLUORESCEIN ANGIOGRAPHY FINDINGS IN PATIENTS WITH PREPROLIFERATIVE DIABETIC RETINOPATHY. Int. J. of Adv. Res. 6 (Feb). 277-286] (ISSN 2320-5407). www.journalijar.com

ISHRAT LONE
GMC SRINAGAR

DOI:

Article DOI: 10.21474/IJAR01/6438      
DOI URL: https://dx.doi.org/10.21474/IJAR01/6438

Download Full Paper

Download PDF No. of Downloads: 47 | No. of Views: 234